These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21338051)

  • 1. Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄.
    Cheung YY; Zamorano R; Blobaum AL; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    ACS Comb Sci; 2011 Mar; 13(2):159-65. PubMed ID: 21338051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS).
    Engers DW; Gentry PR; Williams R; Bolinger JD; Weaver CD; Menon UN; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5175-8. PubMed ID: 20667732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
    Wenthur CJ; Morrison RD; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2693-8. PubMed ID: 24794112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
    Xiong H; Brugel TA; Balestra M; Brown DG; Brush KA; Hightower C; Hinkley L; Hoesch V; Kang J; Koether GM; McCauley JP; McLaren FM; Panko LM; Simpson TR; Smith RW; Woods JM; Brockel B; Chhajlani V; Gadient RA; Spear N; Sygowski LA; Zhang M; Arora J; Breysse N; Wilson JM; Isaac M; Slassi A; King MM
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7381-4. PubMed ID: 21067920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.
    Trabanco AA; Duvey G; Cid JM; Macdonald GJ; Cluzeau P; Nhem V; Furnari R; Behaj N; Poulain G; Finn T; Lavreysen H; Poli S; Raux A; Thollon Y; Poirier N; D'Addona D; Andrés JI; Lutjens R; Le Poul E; Imogai H; Rocher JP
    Bioorg Med Chem Lett; 2011 Feb; 21(3):971-6. PubMed ID: 21232953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of metabotropic glutamate receptors.
    Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
    Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold.
    Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
    Williams R; Johnson KA; Gentry PR; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4967-70. PubMed ID: 19640716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
    Stansley BJ; Conn PJ
    Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.
    Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S
    Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
    Orgován Z; Ferenczy GG; Keserű GM
    ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
    Luessen DJ; Conn PJ
    Pharmacol Rev; 2022 Jul; 74(3):630-661. PubMed ID: 35710132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead optimization of the VU0486321 series of mGlu
    Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW
    Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
    Gregory KJ; Noetzel MJ; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.
    Noetzel MJ; Rook JM; Vinson PN; Cho HP; Days E; Zhou Y; Rodriguez AL; Lavreysen H; Stauffer SR; Niswender CM; Xiang Z; Daniels JS; Jones CK; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2012 Feb; 81(2):120-33. PubMed ID: 22021324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.
    Williams R; Manka JT; Rodriguez AL; Vinson PN; Niswender CM; Weaver CD; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1350-3. PubMed ID: 21315585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.
    D'Alessandro PL; Corti C; Roth A; Ugolini A; Sava A; Montanari D; Bianchi F; Garland SL; Powney B; Koppe EL; Rocheville M; Osborne G; Perez P; de la Fuente J; De Los Frailes M; Smith PW; Branch C; Nash D; Watson SP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):759-62. PubMed ID: 20005096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of a series of mGlu
    Kalbfleisch JJ; Reed CW; Park C; Spearing PK; Quitalig MC; Jenkins MT; Rodriguez AL; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127529. PubMed ID: 32890686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.